
Keywords: انتشار تاخیر; AUC; Area under the concentration-time curve; DR; Delayed release; eGFR; Estimated glomerular filtration rate; FDA; Food and Drug Administration; GLP-1; Glucagon-like peptide 1; MALA; Metformin-associated lactic acidosis; NDA; New Drug Application; XR;